Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on mucopolysaccharidosis type II.
Beck M, Wraith E. Beck M, et al. Among authors: wraith e. Acta Paediatr. 2007 Apr;96(455):55. doi: 10.1111/j.1651-2227.2007.00210.x. Acta Paediatr. 2007. PMID: 17391444 No abstract available.
Laronidase treatment of mucopolysaccharidosis I.
Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA. Wraith EJ, et al. BioDrugs. 2005;19(1):1-7. doi: 10.2165/00063030-200519010-00001. BioDrugs. 2005. PMID: 15691212 Review.
The ocular features of the mucopolysaccharidoses.
Ashworth JL, Biswas S, Wraith E, Lloyd IC. Ashworth JL, et al. Among authors: wraith e. Eye (Lond). 2006 May;20(5):553-63. doi: 10.1038/sj.eye.6701921. Eye (Lond). 2006. PMID: 15905869
Mucopolysaccharidoses and the eye.
Ashworth JL, Biswas S, Wraith E, Lloyd IC. Ashworth JL, et al. Among authors: wraith e. Surv Ophthalmol. 2006 Jan-Feb;51(1):1-17. doi: 10.1016/j.survophthal.2005.11.007. Surv Ophthalmol. 2006. PMID: 16414358 Review.
Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.
Tomatsu S, Okamura K, Taketani T, Orii KO, Nishioka T, Gutierrez MA, Velez-Castrillon S, Fachel AA, Grubb JH, Cooper A, Thornley M, Wraith E, Barrera LA, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Isogai K, Suzuki Y, Orii T, Kondo N, Creer M, Noguchi A. Tomatsu S, et al. Among authors: wraith e. Pediatr Res. 2004 Apr;55(4):592-7. doi: 10.1203/01.PDR.0000113767.60140.E9. Epub 2004 Jan 7. Pediatr Res. 2004. PMID: 14711889
Source document verification in the Mucopolysaccharidosis Type I Registry.
Verhulst K, Artiles-Carloni L, Beck M, Clarke JT, Neto JC, Cox GF, Fernhoff PM, Guffon N, Kong Y, Martins AM, Tylki-Szymanska A, Whitley CB, Wijburg FA, Wraith EJ, Koepper CM. Verhulst K, et al. Among authors: wraith ej. Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):749-752. doi: 10.1002/pds.2200. Epub 2011 Dec 14. Pharmacoepidemiol Drug Saf. 2012. PMID: 22170853
Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses.
Tomatsu S, Okamura K, Maeda H, Taketani T, Castrillon SV, Gutierrez MA, Nishioka T, Fachel AA, Orii KO, Grubb JH, Cooper A, Thornley M, Wraith E, Barrera LA, Laybauer LS, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Haskins M, Isogai K, Suzuki Y, Orii T, Kondo N, Creer M, Okuyama T, Tanaka A, Noguchi A. Tomatsu S, et al. Among authors: wraith e. J Inherit Metab Dis. 2005;28(2):187-202. doi: 10.1007/s10545-005-5673-3. J Inherit Metab Dis. 2005. PMID: 15877208
Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses.
Tomatsu S, Gutierrez MA, Ishimaru T, Peña OM, Montaño AM, Maeda H, Velez-Castrillon S, Nishioka T, Fachel AA, Cooper A, Thornley M, Wraith E, Barrera LA, Laybauer LS, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Isogai K, Suzuki Y, Orii T, Noguchi A. Tomatsu S, et al. Among authors: wraith e. J Inherit Metab Dis. 2005;28(5):743-57. doi: 10.1007/s10545-005-0069-y. J Inherit Metab Dis. 2005. PMID: 16151906
36 results